Latest updates from the NIH

NIH Funding Opportunities and Notices - Posted August 4, 2022

General Notices

• NIH Request for Information (RFI) on Acquiring Electronic Health Record Data from Health Information Networks and Health Information Exchanges for the All of Us Research Program
  (NOT-PM-22-004)
  Office of the Director, NIH

• Request for Information: Soliciting ideas for new NIH Common Fund programs
  (NOT-RM-22-016)
  Office of Strategic Coordination (Common Fund)

Funding Opportunities

• The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
  (RFA-CA-22-039)
  National Cancer Institute
  Application Receipt Date(s): September 08, 2022
• The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
  (RFA-CA-22-040)
  National Cancer Institute
  Application Receipt Date(s): September 08, 2022
• NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)
  (RFA-NS-22-053)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Nursing Research
  Application Receipt Date(s): November 04, 2022

NIH Funding Opportunities and Notices - Posted August 2, 2022

Policy Notices

• eRA Retirement of All Application Form Versions Prior to FORMS-E
  (NOT-OD-22-182)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  Food and Drug Administration

General Notices

• Notice of Change to Language for the Eligible Individual Criteria for PA-21-052: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
  (NOT-OD-22-183)
  Office of the Director, NIH

• Register Today for the NIH Data Management and Sharing (DMS) Policy Webinar Series
  (NOT-OD-22-184)
  Office of the Director, NIH

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
  (NOT-CA-22-110)
  National Cancer Institute
  National Institute of Neurological Disorders and Stroke

• Notice of Intent to Publish a Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)
  (NOT-CA-22-111)
  National Cancer Institute
  National Institute of Neurological Disorders and Stroke

• Notice of Intent to Publish a Funding Opportunity Announcement for Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  (NOT-CA-22-113)
  National Cancer Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required)
  (NOT-NR-22-015)
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke

• Notice of Intent to Publish a Funding Opportunity Announcement for Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
  (NOT-OD-22-168)
  Office of Nutrition Research
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke

Notices of Special Interest

• Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations
  (NOT-MD-22-012)
  National Institute on Minority Health and Health Disparities
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health

• HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery
  (NOT-NS-22-095)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan
  (NOT-OD-22-178)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Dietary Supplements
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
  (NOT-OD-22-179)
  Office of Disease Prevention
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Dietary Supplements
  Office of Research on Women's Health

Funding Opportunities

• Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
  (PAR-22-190)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): November 07, 2022
• Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)
  (PAR-22-203)
  National Institute of Biomedical Imaging and Bioengineering
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  Application Receipt Date(s): January 07, 2023
• Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
  (PAR-22-210)
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
  (PAR-22-216)
  National Cancer Institute
  Application Receipt Date(s): July 01, 2025
• HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
  (PAS-22-206)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Mental Health
  Application Receipt Date(s): November 12, 2025
• HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
  (PAS-22-207)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Mental Health
  Application Receipt Date(s): November 12, 2025
• Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-038)
  National Cancer Institute
  Application Receipt Date(s): Not Applicable
• HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required)
  (RFA-DA-23-041)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): September 27, 2022
• HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
  (RFA-DA-23-051)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute of Mental Health
  Office of Disease Prevention
  Application Receipt Date(s): February 02, 2023

NIH Funding Opportunities and Notices - Posted May 20, 2022

General Notices

• Notice of Pre-application Webinar for NCI Funding Opportunity Announcement for RFA-CA-22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)"
  (NOT-CA-22-087)
  National Cancer Institute

• The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Nutrition as Prevention for Improved Cancer Health Outcomes
  (NOT-OD-22-138)
  Office of Disease Prevention

• Promoting Equity in Global Health Research
  (NOT-TW-22-001)
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke

Notices of Special Interest

• Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
  (NOT-CA-22-038)
  National Cancer Institute
  Office of Disease Prevention

• Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  (NOT-OD-22-126)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke

• Notice of Special Interest: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data
  (NOT-PM-22-002)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health

NIH Funding Opportunities and Notices - Posted May 6, 2022

Notices of Special Interest

• Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy
  (NOT-CA-22-063)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research

• Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer
  (NOT-CA-22-085)
  National Cancer Institute

NIH Funding Opportunities and Notices - Posted March 28, 2022

General Notices

• Pre-Application Webinar for NOT-CA-22-056, Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
  (NOT-CA-22-064)
  National Cancer Institute
  National Institute of Environmental Health Sciences

• Notice of NCI Participation in RFA-MD-22-008, Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
  (NOT-CA-22-066)
  National Cancer Institute

• Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)
  (NOT-HG-22-006)
  National Human Genome Research Institute
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Research on Women's Health

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
  (NOT-CA-22-057)
  National Cancer Institute

• Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging
  (NOT-EB-22-006)
  National Institute of Biomedical Imaging and Bioengineering

Funding Opportunities

• Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
  (PAR-22-126)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
  (PAR-22-127)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed)
  (RFA-CA-22-012)
  National Cancer Institute
  Application Receipt Date(s): November 01, 2022
• PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)
  (RFA-CA-22-013)
  National Cancer Institute
  Application Receipt Date(s): November 01, 2022
• Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
  (RFA-CA-22-017)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
  (RFA-CA-22-021)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
  (RFA-CA-22-022)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-22-023)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-22-024)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
  (RFA-MD-22-008)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): November 13, 2022

NIH Funding Opportunities and Notices - Posted January 2, 2022

General Notices

• Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic
  (NOT-OD-22-046)
  Office of the Director, NIH

• Notice of Pre-Application Webinar and FAQs for RFA-OD-22-002 Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)
  (NOT-OD-22-052)
  Office of Disease Prevention

• Request for Information (RFI): Inviting Comments and Suggestions on Updating the Strategic Plan for Trans-NIH Research to Cure Hepatitis B
  (NOT-AI-22-018)
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities

• Request for Information (RFI): Research Challenges and Needs in the Interaction of Sleep and Emotion Regulation to Improve Health and Well-being across Health Conditions
  (NOT-OD-22-053)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Heart, Lung, and Blood Institute

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
  (NOT-CA-22-026)
  National Cancer Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for Copy of Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
  (NOT-CA-22-027)
  National Cancer Institute

• Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
  (NOT-CA-22-030)
  National Cancer Institute

NIH Funding Opportunities and Notices - Posted December 29, 2021

Notice of Changes to Funding Opportunities

• Notice of NCI's Participation in PAR-20-070, "Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)"
  (NOT-CA-22-023)
  National Cancer Institute

• Notice to Extend the Response Date for NOT-CA-22-004 "Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers"
  (NOT-CA-22-024)
  National Cancer Institute

Requests for Proposal

• Request for Proposals FNIH Cancer Steering Committee Project Concepts for Novel Biomarker Platforms to Support Novel Tissue Imaging, Remote Sensing, and Toxicity Challenges
  (NOT-CA-22-028)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
  (NOT-HL-23-001)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke

• Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
  (NOT-MD-22-006)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health

NIH Funding Opportunities and Notices - Posted December 20, 2021

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities (R01 Clinical Trials Optional)
  (NOT-MD-22-008)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Nursing Research
  Office of Research on Women's Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
  (NOT-NR-22-004)
  National Institute of Nursing Research
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
  (NOT-NS-22-040)
  National Institute of Neurological Disorders and Stroke
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Nursing Research
  Office of Research on Women's Health

Notices of Special Interest

• Notice of Special Interest: National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program for Pre- and Postdoctoral Candidates from Diverse Backgrounds
  (NOT-AT-21-013)
  National Center for Complementary and Integrative Health

• Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
  (NOT-OD-22-026)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Research on Women's Health

Funding Opportunities

• Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
  (PAR-21-358)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
  (RFA-AT-22-006)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): March 15, 2022
• Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)
  (RFA-OD-22-002)
  Office of Disease Prevention
  National Cancer Institute
  Application Receipt Date(s): May 18, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Funding Opportunities and Notices - Posted December 17, 2021

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to Harmonize / Map Existing Data to NCI Human Tumor Atlas Network Data Standards
  (NOT-CA-22-013)
  National Cancer Institute

• Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment
  (NOT-CA-22-014)
  National Cancer Institute

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported Drug Resistance and Sensitivity Network (DRSN)
  (NOT-CA-22-020)
  National Cancer Institute

• Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease
  (NOT-HG-22-007)
  National Human Genome Research Institute

• Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects
  (NOT-OD-22-022)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences

• Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
  (NOT-OD-22-023)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection
  (NOT-OD-22-038)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Disease Prevention
  Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research
  (NOT-OD-22-039)
  Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs

Funding Opportunities

• AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01)
  (PA-22-049)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): March 12, 2025
• AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08)
  (PA-22-050)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): March 12, 2025
• AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)
  (PA-22-051)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): July 12, 2025
• Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
  (RFA-EB-21-001)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
  (RFA-HG-22-001)
  National Human Genome Research Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
  (RFA-RM-22-007)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): February 18, 2022

NIH Funding Opportunities and Notices - Posted November 25, 2021

Funding Opportunities

• Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
  (PAR-22-071)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2024
• Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
  (PAR-22-072)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
  (RFA-CA-22-001)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022
• Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
  (RFA-CA-22-002)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022

NIH Funding Opportunities and Notices - Posted November 5, 2021

Notice of Changes to Funding Opportunities

• Notice of Correction to Funding Opportunity Announcement (FOA) PAR-21-065, "Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)"
  (NOT-CA-22-007)
  National Cancer Institute

• Notice of Correction in Expiration Date for PAR-22-049, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)"
  (NOT-CA-22-008)
  National Cancer Institute

• Notice of Change to Eligibility of Foreign Components for RFA-CA-21-047, "Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)"
  (NOT-CA-22-009)
  National Cancer Institute

• Notice of Participation of OBSSR in PAR-21-277, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
  (NOT-OD-22-016)
  Office of Behavioral and Social Sciences Research

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
  (NOT-OD-22-011)
  Office of Disease Prevention
  National Institute on Drug Abuse

• Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
  (NOT-OD-22-017)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences

Notices of Special Interest

• Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity
  (NOT-CA-22-001)
  National Cancer Institute
  National Heart, Lung, and Blood Institute

Funding Opportunities

• Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (PAR-22-054)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): February 23, 2022
• Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
  (PAR-22-061)
  National Cancer Institute
  Application Receipt Date(s): January 07, 2025
• Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
  (PAR-22-062)
  National Cancer Institute
  Application Receipt Date(s): January 07, 2025
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-CA-21-060)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
  (RFA-CA-21-061)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
  (RFA-CA-21-062)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2022
• Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
  (RFA-CA-22-003)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022
• Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
  (RFA-CA-22-004)
  National Cancer Institute
  Application Receipt Date(s): September 22, 2022

NIH Funding Opportunities and Notices - Posted October 29, 2021

General Notices

• Notice of Participation of OBSSR in PAR-21-271 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  (NOT-OD-22-013)
  Office of Behavioral and Social Sciences Research
  
• Notice of Participation of OBSSR in PAR-21-272 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)
  (NOT-OD-22-014)
  Office of Behavioral and Social Sciences Research
  
• Notice of Participation of the Office of Behavioral and Social Sciences Research (OBSSR) in PAR-21-273 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 -
  (NOT-OD-22-015)
  Office of Behavioral and Social Sciences Research
  
• Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers
  (NOT-CA-22-004)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Clinical Characterization and Intervention Strategies for Cancer Therapy Induced Adverse Sequelae
  (NOT-CA-22-005)
  National Cancer Institute

NIH Funding Opportunities and Notices - Posted October 15, 2021

Funding Opportunities

• Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
  (PAR-21-341)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.

NIH Funding Opportunities and Notices - Posted October 1, 2021

General Notices

• Review of the Accuracy of Grants Information for Fiscal Year 2021
  (NOT-OD-21-186)
  National Institutes of Health

Funding Opportunities

• Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
  (PAR-21-344)
  John E. Fogarty International Center
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): December 20, 2022
• The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
  (PAR-21-348)
  National Cancer Institute
  Application Receipt Date(s): December 15, 2023

NIH Funding Opportunities and Notices - Posted September 24, 2021

Policy Notices

• Notice to Extend PA-20-074 "Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support (R18)"
  (NOT-HS-21-021)
  Agency for Healthcare Research and Quality

• Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Awards
  (NOT-OD-21-177)
  National Institutes of Health

General Notices

• NIDCR Guidance on Applications for Investigator-Initiated Clinical Trials
  (NOT-DE-21-014)
  National Institute of Dental and Craniofacial Research

Notice of Changes to Funding Opportunities

• Notice of Correction to Salary information in PAR-21-295, NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  (NOT-CA-21-116)
  National Cancer Institute

• Notice of Correction to PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
  (NOT-CA-21-119)
  National Cancer Institute

• Notice of Early Termination of RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)"
  (NOT-CA-21-120)
  National Cancer Institute

Funding Opportunities

 

• Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
  (PAR-21-329)
  National Cancer Institute
  Application Receipt Date(s): November 05, 2024
• SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
  (RFA-AI-21-060)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 15, 2022
• Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed)
  (RFA-AI-21-068)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 09, 2022
• INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
  (RFA-OD-21-007)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.

NIH Funding Opportunities and Notices - Posted September 3, 2021

Notice of Changes to Funding Opportunities

• Notice of Change to the Expiration Date and the Last Receipt Date of PAR-19-287, "Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)"
  (NOT-CA-21-110)
  National Cancer Institute

Funding Opportunities

• NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  (PAR-21-295)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
  (PAR-21-296)
  National Cancer Institute
  Application Receipt Date(s): November 12, 2024
• Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
  (PAR-21-322)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2024
• Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
  (PAR-21-323)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2024
• Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)
  (PAR-21-324)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2024
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
  (PAR-21-331)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
  (PAR-21-332)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
  (RFA-CA-21-020)
  National Cancer Institute
  Application Receipt Date(s): September 28, 2022; September 28, 2023 No late applications will be accepted for this Funding Opportunity Announcement.
• Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-055)
  National Cancer Institute
  Application Receipt Date(s): November 2, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Funding Opportunities and Notices - Posted August 20, 2021

General Notices

• Notice of Pre-Application Webinar for Acquired Resistance to Therapy Network (ARTNet) and its Coordinating and Data Management Center (RFA-CA-21-052 and RFA-CA-21-053)
  (NOT-CA-21-111)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules
  (NOT-CA-21-101)
  National Cancer Institute

Funding Opportunities

• NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
  (PAR-21-306)
  National Cancer Institute
  Application Receipt Date(s): October 06, 2023

NIH Funding Opportunities and Notices - Posted August 13, 2021

Policy Notices

• Notice of Intent to Publish Funding Announcement for Strategies to Implement Evidence-based Care to Reduce High Burden Racial and Ethnic Disparities
  (NOT-HS-21-019)
  Agency for Healthcare Research and Quality

General Notices

• Notice of Pre-Application Webinar for the "Program on the Origins of Gastroesophageal Cancers": RFA-CA-21-026 and RFA-CA-21-027
  (NOT-CA-21-107)
  National Cancer Institute

Funding Opportunities

• Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
  (PAR-21-305)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Disease Prevention
  Application Receipt Date(s): January 10, 2022; February 10, 2022; March 10, 2022; April 11, 2022; May 10, 2022; June 9, 2022; July 11, 2022; August 9, 2022; September 9, 2022; October 7, 2022; November 9, 2022; December 9, 2022; January 10, 2023; February 9, 2023; March 9, 2023; April 11, 2023; May 9, 2023; June 9, 2023; July 11, 2023; August 9, 2023; September 8, 2023; October 10, 2023; November 9, 2023; December 11, 2023; January 9, 2024; February 9, 2024; March 8, 2024; April 9, 2024; May 8, 2024; June 10, 2024, July 9, 2024; August 9, 2024; and September 10, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Funding Opportunities and Notices - Posted August 6, 2021

Policy Notices

• New NIH "FORMS-G" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2022
  (NOT-OD-21-169)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  Food and Drug Administration

General Notices

• Pre-Application Webinar for RFA-CA-21-050, Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) and RFA-CA-21-051, Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
  (NOT-CA-21-103)
  National Cancer Institute

• Pre-application Webinar for RFA-CA-21-048 - Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)
  (NOT-CA-21-104)
  National Cancer Institute

• Pre-application Webinar for RFA-CA-21-049 - Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-CA-21-105)
  National Cancer Institute

• Pre-Application Webinar for the "PDAC Stromal Reprogramming Consortium (PSRC)": RFA-CA-21-041 and RFA-CA-21-042
  (NOT-CA-21-106)
  National Cancer Institute

• Extension of COVID Flexibilities for Instruction in the Responsible Conduct of Research
  (NOT-OD-21-152)
  National Institutes of Health
  Agency for Healthcare Research and Quality

• Adjusted Timeline for Requiring Two-Factor Authentication to Access eRA Modules Using Login.Gov or InCommon Federated Accounts
  (NOT-OD-21-172)
  National Institutes of Health

• Critical resource gaps and opportunities to support Next Generation Sequencing (NGS) test development, validation, and data interpretation, including through the use of technologies such as artificial intelligence (AI)/machine learning (ML).
  (NOT-OD-21-162)
  Office of the Director, NIH
  Food and Drug Administration

• Request for Information: Critical resource gaps and opportunities to support radiological tool development and clinical data interpretation using artificial intelligence (AI)/machine learning (ML)
  (NOT-OD-21-163)
  Office of the Director, NIH
  Food and Drug Administration

Notice of Changes to Funding Opportunities

• Notice to Extend Expiration Date and Add a Receipt Date for PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
  (NOT-OD-21-168)
  Office of Disease Prevention
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP)
  (NOT-CA-21-100)
  National Cancer Institute
  Office of Research on Women's Health

• Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions
  (NOT-DE-21-010)
  National Institute of Dental and Craniofacial Research
  National Cancer Institute

Funding Opportunities

 

• Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
  (RFA-HG-21-033)
  National Human Genome Research Institute
  Application Receipt Date(s): July 1, 2022; July 1, 2023, All applications are due by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Funding Opportunities and Notices - Posted July 23, 2021

General Notices

• Notice of Information: Guidance Regarding Minimum Level of Effort for NCI-Funded Awards
  (NOT-CA-21-096)
  National Cancer Institute

Funding Opportunities

• Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
  (PAR-21-247)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 15, 2022; June 15, 2023, All applications are due by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
  (PAR-21-274)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.

NIH Funding Opportunities and Notices - Posted June 25, 2021

General Notices

• Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer (RFA-RM-21-015), New Innovator (RFA-RM-21-016), Transformative Research (RFA-RM-21-017), and Early Independence (RFA-RM-21-018) Awards
  (NOT-RM-21-017)
  Office of Strategic Coordination (Common Fund)

• Request for Information (RFI): Input for National Cancer Institute (NCI) Pediatric Immunotherapy Network
  (NOT-CA-21-086)
  National Cancer Institute

• Request for Information (RFI) on Datasets Collecting Temporally-Linked Diet, Physical Activity, and Sleep Data to Facilitate Integrated Research on 24-Hour Behavior Patterns
  (NOT-CA-21-087)
  National Cancer Institute

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
  (NOT-CA-21-084)
  National Cancer Institute

Weekly NIH Funding Opportunities and Notices for March 19, 2021

Policy Notices

• Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
  (NOT-OD-21-074)
  National Institutes of Health

Notice of Changes to Funding Opportunities

• Notice of Correction to Application and Submission Information for NOSI: Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (NOT-OD-21-070)
  (NOT-OD-21-075)
  National Institutes of Health
  
• Notice of Change to NOT-OD-20-024: Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  (NOT-OD-21-076)
  National Institutes of Health
  
• Notice of Change to NOT-OD-20-025: Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  (NOT-OD-21-077)
  National Institutes of Health

Notices of Special Interest

• Notice of Special Interest (NOSI): Fundamental Science Research on Complementary and Integrative Health Approaches
  (NOT-AT-21-006)
  National Center for Complementary and Integrative Health
  
• Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
  (NOT-CA-21-041)
  National Cancer Institute
  
• Notice of Special Interest (NOSI) to add harassment as an area of interest to Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences
  (NOT-OD-21-068)
  Office of Research on Women's Health
  National Cancer Institute
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research

Funding Opportunities

• Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
  (PAR-21-061)
  National Cancer Institute
  Application Receipt Date(s): June 14, 2022; November 17, 2022; June 14, 2023; November 17, 2023
  
• The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)
  (PAR-21-111)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
  
• The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  (PAR-21-128)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
  
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
  (PAR-21-170)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required)
  (PAR-21-171)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed)
  (PAR-21-172)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
• Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
  (PAR-21-173)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
• The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
  (PAR-21-318)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
  
• Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)
  (RFA-AI-21-020)
  National Institute of Allergy and Infectious Diseases
  
  Application Receipt Date(s): Multiple dates, see announcement.
• Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
  (RFA-AI-21-021)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
• Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)
  (RFA-AI-21-035)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.

Updates from December 28, 2020

Notice of Changes to Funding Opportunities

• Notice of Changed Application Forms for RFA-CA-20-049 "New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)"
  (NOT-CA-21-024)
  National Cancer Institute

Requests for Proposal

• Pre Solicitation Notice: Clinical Pharmacology Quality Assurance (CPQA) Program, RFP: 75N93021R00003
  (NOT-AI-21-010)
  National Institute of Allergy and Infectious Diseases

Notices of Special Interest

• Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
  (NOT-HD-20-039)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  
• Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
  (NOT-MD-21-008)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health

Updates from December 11, 2020

General Notices

• Notice of Informational Webinar for RFA-CA-20-055, RFA-CA-20-056, and RFA-CA-20-057: "Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)"
  (NOT-CA-21-022)
  National Cancer Institute

• Notice of Pre-Application Webinar for the NCI-CRUK Cancer Grand Challenges
  (NOT-CA-21-023)
  National Cancer Institute

• Required Use of Two-Factor Authentication Using Login.Gov for eRA's External Modules in 2021
  (NOT-OD-21-040)
  National Institutes of Health

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
  (NOT-CA-21-021)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways
  (NOT-CA-21-019)
  National Cancer Institute
  

Updates from November 23, 2020

Policy Notices

• NIH Implementation of the Revised Federal-wide Research Terms and Conditions
  (NOT-OD-21-029)
  National Institutes of Health

General Notices

• Pre-Application Webinar for RFA-CA-20-054, Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
  (NOT-CA-21-017)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Cellular Cancer Biology Imaging Research (CCBIR) Program (U54 Clinical Trial Not Allowed)
  (NOT-CA-21-016)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported PDX Development and Trial Centers Research Network (PDXNet)
  (NOT-CA-21-009)
  National Cancer Institute

• Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities
  (NOT-ES-21-002)
  National Institute of Environmental Health Sciences
  
• Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
  (NOT-OD-21-020)
  National Institutes of Health
  National Cancer Institute
  

Funding Opportunities

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
  (PA-21-071)
  National Institutes of Health
  National Cancer Institute
  Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Due dates vary by awarding IC Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
  (PAR-21-022)
  National Institute on Drug Abuse
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 19, 2022; November 15, 2022; July 19, 2023; November 15, 2023. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)
  (PAR-21-025)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 28, 2022; January 30, 2023, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)
  (PAR-21-026)
  National Institute of General Medical Sciences
  Application Receipt Date(s): January 30, 2023  
• Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)
  (PAR-21-080)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply.
• Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)
  (PAR-21-081)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Standard AIDS dates apply.

Updates from November 13, 2020

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed)
  (NOT-RM-21-001)
  Office of Strategic Coordination (Common Fund)

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24)
  (NOT-RM-21-002)
  Office of Strategic Coordination (Common Fund)

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)
  (NOT-RM-21-003)
  Office of Strategic Coordination (Common Fund)

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)
  (NOT-RM-21-006)
  Office of Strategic Coordination (Common Fund)

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required)
  (NOT-RM-21-007)
  Office of Strategic Coordination (Common Fund)

• Notice of Intent to Publish a Funding Opportunity Announcement for Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-RM-21-008)
  Office of Strategic Coordination (Common Fund)

Notices of Special Interest

• Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
  (NOT-AI-21-002)
  National Institute of Allergy and Infectious Diseases

• NOSI: Academy of Finland (AKA) National Institutes of Health (NIH) Partnership Program
  (NOT-OD-21-021)
  National Institutes of Health
  National Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases

Funding Opportunities

• Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
  (PAR-21-038)
  National Institutes of Health
  Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs
  Office of Research on Women's Health
  Application Receipt Date(s): January 26, 2022; May 26, 2022; September 27, 2022; January 26, 2023; May 26, 2023; September 26, 2023
• Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)
  (PAR-21-039)
  National Institutes of Health
  Office of Research on Women's Health
  Application Receipt Date(s): January 26, 2022; May 26, 2022; September 27, 2022; January 26, 2023; May 26, 2023; September 26, 2023

Updates from November 7, 2020

Policy Notices

• AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
  (NOT-HS-21-002)
  Agency for Healthcare Research and Quality

• Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
  (NOT-OD-21-026)
  National Institutes of Health

Notice of Changes to Funding Opportunities

• Notice of Extension of the Expiration Date for PAR-18-530 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)"
  (NOT-CA-21-007)
  National Cancer Institute

Requests for Proposal

• Presolicitation Notice: Request for Proposals (RFP) 75N91021R00007 "Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients"
  (NOT-CA-21-011)
  National Cancer Institute

• Presolicitation Notice: Request for Proposals (RFP) 75N91021R00003 "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications"
  (NOT-CA-21-012)
  National Cancer Institute

• Presolicitation Notice: Request for Proposals (RFP) 75N91021R00004"Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications"
  (NOT-CA-21-013)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to Adapt/Repackage Visualization Methods for Enhancing Cancer Moonshot Data
  (NOT-CA-21-008)
  National Cancer Institute

Funding Opportunities

• Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)
  (PAR-20-315)
  National Institutes of Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Rolling receipt dates: January 31, 2022; February 1, 2022 May 31, 2022; June 1, 2022 September 30, 2022; October 1, 2022- January 31, 2023; February 1, 2023 - May 31, 2023; June 1, 2023 September 30, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Updates from September 25, 2020

Policy Notices

• Changes to the HHS Notice of Award (NoA) Beginning October 1, 2020
  (NOT-HS-20-017)
  Agency for Healthcare Research and Quality

General Notices

• Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-20-084)
  (NOT-EB-20-019)
  National Institute of Biomedical Imaging and Bioengineering

• Notice of NIMHD Participation in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)"
  (NOT-MD-20-028)
  National Institute on Minority Health and Health Disparities

• Request for Information (RFI): Pediatric preclinical models (cell lines and patient-derived xenografts) for which genomic characterization will enhance the research value
  (NOT-CA-20-108)
  National Cancer Institute

Notice of Changes to Funding Opportunities

• Notice of FY2021 Cohort Dates for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
  (NOT-CA-20-106)
  National Cancer Institute

• Notice of Correction to PAR-20-295 Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection In Vivo (R01 Clinical Trials optional)
  (NOT-CA-20-107)
  National Cancer Institute

Updates from September 24, 2020

Policy Notices

• Reminder: NIH Policy on Use of Hypertext in NIH Grant Applications
  (NOT-OD-20-174)
  National Institutes of Health

Funding Opportunities

• Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
  (RFA-CA-20-051)
  National Cancer Institute
  Office of Disease Prevention
  Application Receipt Date(s): January 18, 2022, No late applications will be accepted for this Funding Opportunity Announcement.